Safety, tolerability, PK/PD and preliminary efficacy of NKTR-255, a novel IL-15 receptor agonist, in patients with relapsed/refractory hematologic malignancies Meeting Abstract
| Authors: | Shah, N.; Tan, A.; Budde, E.; Hofmeister, C. C.; Cowan, A. J.; Perales, M. A.; Choi, T.; Saeed, H.; Chavez, J. C.; Ye, J. C.; Cairo, M. S.; Rizzieri, D. A.; Orloff, G. J.; Lee, Z.; Dixit, N.; Nieves, W.; Zhao, Q.; Wang, X.; Kai, K.; Marcondes, M. Q.; Tagliaferri, M. A.; Zalevsky, J.; Patel, K. K. |
| Abstract Title: | Safety, tolerability, PK/PD and preliminary efficacy of NKTR-255, a novel IL-15 receptor agonist, in patients with relapsed/refractory hematologic malignancies |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736413904204 |
| DOI: | 10.1182/blood-2021-147758 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3134 -- Hybrid meeting, also took place online -- Source: Wos |
